Advertisement

Topics

CEL-SCI Corporation Company Profile

16:28 EST 17th November 2017 | BioPortfolio

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine. In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve the patients' overall survival by 33 percent at a median of three and a half years following surgery. A pivotal Phase III clinical trial with Multikine in head and neck cancer is expected to start in the second half of 2010.


News Articles [62 Associated News Articles listed on BioPortfolio]

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Orion Corporation: Managers' transactions - Hilpi Rautelin

ORION CORPORATION      MANAGERS' TRANSACTIONS 1st of November 2017 at 22.15 EET              Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Cor...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 ...

Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation

EAST RUTHERFORD, N.J., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), t...

Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDerm

REHOVOT, Israel, Oct. 18, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disor...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [171 Associated Companies listed on BioPortfolio]

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Hot Spring Spas

Hot Spring Spas is the world’s leading brand of hot tubs and is sold through a network of more than 700 independent dealers throughout North America and 70 countries around t...

TOSHIBA TEC CORPORATION

TOSHIBA TEC CORPORATION is engaged in digital product business of the TOSHIBA group. Expanding its operation for the whole world, the range of products is formed by POS ...

More Information about "CEL-SCI Corporation" on BioPortfolio

We have published hundreds of CEL-SCI Corporation news stories on BioPortfolio along with dozens of CEL-SCI Corporation Clinical Trials and PubMed Articles about CEL-SCI Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CEL-SCI Corporation Companies in our database. You can also find out about relevant CEL-SCI Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record